Prevalence of Disruptive Behavior in Children With Attention Deficit Hyperactivity Disorder(ADHD)

October 4, 2021 updated by: Eman Sayed Hassan Mahros

Clinical Observational and Statistical Study for Detection of Prevalence and Risk Factors of Disruptive Behavior in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Identification of prevalence and Risk factors for disruptive behavior in children with Attention Deficit Hyperactivity Disorder and Early recognition of disruptive behavior in children with ADHD

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

ADHD is asustaible pattern of inattention Hyperactivity and lmpulsive behavior which can have harmful consequences for the patients social life it was called childhood hyperkinetic reaction before it is estimated that 3 to 5 percent of children show symptoms in primary school in addition to the role of genetic factor in the incidence of this mental disorder ,family imbalance and other anxiety factors play arole in the continuity of disorder.disruptive behavior with a prevalence of 1 to 10percent is a prevalent disorder in primary school similar to ADHD it is 4 to 12 times more frequent among boys compared with girls . disruptive behavior characterized by aggression and violating others rights . This study is screening survey questionnaire study will be done in Assuit University children hospital Neuro psychiatric outpatient clinic in all children under 18 years old have ADHD and exclude other psychiatric problems as :Autism , depression , Schizophrenia or mental retardation . investigator will take full history : personal history : name , date of birth ,age,sex ,age of onset of ADHD ,type of ADHD,severity of ADHD ,type of disruptive behavior , history of treatment,Family history : sibling have ADHD,smoking of parents,drug use parents,social problems: divorce or death of parents . Investigator will use DSM V criteria as adignostic criteria and screening data evaluated by ADHD symptoms check list -4 (ADHD -sc4 scale scores) : symptoms count scores and symptoms severity scores . All for detect outcome of the patient with ADHD .

Study Type

Observational

Enrollment (Anticipated)

3

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patient with ADHD that meet the selection criteria in the period from October 2021 till June 2022

Description

Inclusion Criteria:

  • All children under 18 years old with ADHD at Neuro pyshictric outpatient clinic

Exclusion Criteria:

  • Any psychiatric problems other than ADHD like :Autism, depression, schizophrenia or mental retardation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of prevalence of disruptive behavior in children with ADHD by Sc -4 scale and DSM V score
Time Frame: Primarily from October 2021 till June 2022
Screening data by ADHD symptoms chick list -4 rating scale(ADHD Sc-4 scale ) to detect symptoms count score and also invistigator use Diagnostic and Statistical Manual of mental disorders fifth edition(DSM V score) to assess the severity of symptoms
Primarily from October 2021 till June 2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Eman Sayed Hassan Mahros

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2021

Primary Completion (Anticipated)

June 1, 2022

Study Completion (Anticipated)

October 1, 2022

Study Registration Dates

First Submitted

September 18, 2021

First Submitted That Met QC Criteria

October 4, 2021

First Posted (Actual)

October 7, 2021

Study Record Updates

Last Update Posted (Actual)

October 7, 2021

Last Update Submitted That Met QC Criteria

October 4, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 271087

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention Deficit Hyperactivity Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe